Publication | Closed Access
Rifaximin in nonalcoholic fatty liver disease: hit multiple targets with a single shot
90
Citations
30
References
2018
Year
Rifaximin therapy appears to be effective and safe in modifying NASH through reduction of serum endotoxin and improvement of insulin resistance, proinflammatory cytokines, CK-18, and NAFLD-liver fat score.
| Year | Citations | |
|---|---|---|
Page 1
Page 1